Found 8 matching trials
A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD) PHASE3 The purpose of this study is to determine if LY03005 is effective and safe ...
Show More Location
The Sixth Hospital of Peking University
Learn More & Join Trial
Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD) PHASE1 This study was a multicenter, randomized, double-blind, placebo, parallel-c...
Show More Location
Approval Letter of Ethics Committee of The Sixth Hospital of Peking University
Learn More & Join Trial
Relative Bioavailability (RBA) Study of LY03005 vs Pristiq® PHASE1 The objective of this study is to evaluate relative bioavailability between...
Show More Learn More & Join Trial
A Study of LY03005 vs Pristiq PHASE1 The objective of this study is to evaluate relative bioavailability between...
Show More Location
Pharmaron CPC, Inc.
Learn More & Join Trial
Safety, Tolerability and Pharmacokinetics Study of LY03005 PHASE1 The purpose of this study is to evaluate the safety and tolerability of esc...
Show More Learn More & Join Trial
A Relative Bioavailability Food Effect Study of LY03005 PHASE1 The objective if this study is to assess the relative bio-availability of s...
Show More Location
Pharmaron CPC, Inc.
Learn More & Join Trial
Pilot BA Study of New LY03005 vs Pristiq PHASE1 The objects of this study is to assess the relative bioavailability (BA) of...
Show More Learn More & Join Trial
Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005 PHASE1 Objectives
* To evaluate the safety and tolerability of escalating multipl...
Show More Location
PRA Health Sciences
Learn More & Join Trial